Rosetta Genomics Gets Patent Allowance For microRNA-based Ovarian Cancer Treatment
July 11, 2016 at 12:05 PM EDT
Rosetta Genomics Ltd. (NASDAQ: ROSG) revealed that the Patent and Trademark Office in the United States has issued a notice of ...
